Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-04

FDA Approved: FESOTERODINE FUMARATE — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals Inc.'s original application for fesoterodine fumarate, a generic treatment for overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fesoterodine fumarate (fesoterodine fumarate)

Snippet

ORIG AP for FESOTERODINE FUMARATE (FESOTERODINE FUMARATE)